Monday, November 23, 2015 1:34:38 PM
Bionik Laboratories Corp. a pioneering medical device and robotics company with a focus in developing technologies and solutions for individuals with neurological disorders gave a presentation at the 14th Annual BIO Investor Forum held October 20-21, 2015 at the Parc 55 in San Francisco, California.
Peter Bloch, CEO of Bionik, presented a corporate overview. As part of his presentation he reviewed the Company's plans for the clinical development and commercial deployment of its primary product ARKE, a proprietary lower-body exoskeleton robotic device that is designed to allow paraplegics as well as other wheelchair users the ability to rehabilitate through walking and other motion. Mr. Bloch also discussed Bionik's near-term strategy to expand and develop a robust product portfolio both internally and by acquiring or licensing synergistic products and technologies.
A live webcast of the presentation is available on Bionik's IR Calendar in the Investor Relations section of the Company's website. A webcast replay is available and will be archived for 30 days.
Recent BNKL News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 06/30/2023 08:31:36 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM